Incidence, Prevalence, and Geographical Clustering of Motor Neuron Disease in the Netherlands
Open Access
- 23 February 2021
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 96 (8), e1227-e1236
- https://doi.org/10.1212/wnl.0000000000011467
Abstract
Objective To assess time trends in motor neuron disease (MND) incidence, prevalence, and mortality and to investigate geographic clustering of MND cases in the Netherlands from 1998 to 2017, we analyzed data from the Netherlands Personal Records database, the Netherlands MND Center, and the Netherlands Patient Association of Neuromuscular Diseases. Methods In this prospective cohort study, Poisson regression was used to assess time trends in MND risk. We calculated age- and sex-standardized, observed, and expected cases for 1,694 areas. Bayesian smoothed risk mapping was used to investigate geographic MND risk. Results We identified 7,992 MND cases, reflecting an incidence of 2.64 (95% confidence interval [CI] 2.62–2.67) per 100,000 person-years and a prevalence of 9.5 (95% CI 9.1–10.0) per 100,000 persons. Highest age-standardized prevalence and mortality rates occurred at a later age in men than in women (p < 0.001). Unadjusted mortality rates increased by 53.2% from 2.57 per 100,000 person-years in 1998 to 3.86 per 100,000 person-years in 2017. After adjustment for age and sex, an increase in MND mortality rate of 14.1% (95% CI 5.7%–23.2%, p < 0.001) remained. MND relative risk ranged from 0.78 to 1.43 between geographic areas; multiple urban and rural high-risk areas were identified. Conclusions We found a significant national increase in MND mortality from 1998 through 2017, explained only partly by an aging Dutch population, and a geographic variability in MND risk, suggesting a role for environmental or demographic risk factors.This publication has 44 references indexed in Scilit:
- Smoking, Alcohol Consumption, and the Risk of Amyotrophic Lateral Sclerosis: A Population-based StudyAmerican Journal of Epidemiology, 2012
- Population based epidemiology of amyotrophic lateral sclerosis using capture-recapture methodologyJournal of Neurology, Neurosurgery & Psychiatry, 2011
- An estimate of amyotrophic lateral sclerosis heritability using twin dataJournal of Neurology, Neurosurgery & Psychiatry, 2010
- The role of patient advocacy organisations in neuromuscular disease R&D – The case of the Dutch neuromuscular disease association VSNNeuromuscular Disorders, 2010
- Neyman's bias re-visitedJournal of Clinical Epidemiology, 2003
- Capture-recapture methods—useful or misleading?International Journal of Epidemiology, 2001
- Cluster analysis and disease mapping--why, when, and how? A step by step guideBMJ, 1996
- Longitudinal gompertzian analysis of ALS mortality in England and Wales, 1963–1989: Estimates of susceptibility in the general populationMechanisms of Ageing and Development, 1992
- Guam Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Linked to a Plant Excitant NeurotoxinScience, 1987
- Human Immunodeficiency Virus Infections among Civilian Applicants for United States Military Service, October 1985 to March 1986The New England Journal of Medicine, 1987